WHO ICTRP trial

Study of impact of switching from existing long-acting insulin to insulin…

JPRN-UMIN000012459 · Japan Primary Registries Network (JPRN) · Not Recruiting

Key facts

Trial ID JPRN-UMIN000012459
Public title Study of impact of switching from existing long-acting insulin to insulin degludec, a new long-acting insulin, on glycemic control and frequency of hypoglycemia
Scientific title Study of impact of switching from existing long-acting insulin to insulin degludec, a new long-acting insulin, on glycemic control and frequency of hypoglycemia - Study of glycemic control and frequency of hypoglycemia after switching to insulin degludec
Primary sponsor The Third Department of Internal Medicine(Department of Diabetes, Endocrinology and Metabolism),Tokyo Medical University
Registry Japan Primary Registries Network (JPRN)
Recruitment status Not Recruiting
Study type Interventional
Phase Not selected
Countries Japan
Conditions type 2 diabetes
Interventions Study of glycemic control and frequency of hypoglycemia after switching to insulin degludec
Registration date Feb 12, 2013
Target size 50
Registry page center6.umin.ac.jp

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations